Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes
Abstract. The aim of the study was to evaluate the possibility of using copeptin as a marker of renal and metabolic dysfunction in patients with type 2 diabetes. Methods: In this cross-sectional, observational study included 78 patients with type 2 diabetes mellitus complicated by diabetic nephr...
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
National Kidney Foundation of Ukraine
2022-06-01
|
| سلاسل: | Український Журнал Нефрології та Діалізу |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ukrjnd.com.ua/index.php/journal/article/view/646 |